+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Breast Cancer Liquid Biopsy Testing Devices Market Research Report by Offerings (Assay & Reagents Kits and Instruments), Circulating Biomarker, Applications, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 224 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5715461
UP TO OFF until Mar 31st 2023
The Global Breast Cancer Liquid Biopsy Testing Devices Market size was estimated at USD 721.23 million in 2022, USD 858.76 million in 2023, and is projected to grow at a CAGR of 19.52% to reach USD 3,004.57 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Breast Cancer Liquid Biopsy Testing Devices Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Breast Cancer Liquid Biopsy Testing Devices Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Breast Cancer Liquid Biopsy Testing Devices Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Breast Cancer Liquid Biopsy Testing Devices Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Breast Cancer Liquid Biopsy Testing Devices Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Offerings, the market is studied across Assay & Reagents Kits and Instruments.
  • Based on Circulating Biomarker, the market is studied across Circulating Tumar DNA, Circulating Tumor Cell, and Extracellular Vesicles.
  • Based on Applications, the market is studied across Cancer Applications and Non-Cancer Applications.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Breast Cancer Liquid Biopsy Testing Devices Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Breast Cancer Liquid Biopsy Testing Devices Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Breast Cancer Liquid Biopsy Testing Devices Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Breast Cancer Liquid Biopsy Testing Devices Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Breast Cancer Liquid Biopsy Testing Devices Market, including Bio-Rad Laboratories, Inc., Biocept, Inc., Biodesix, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fluxion Biosciences Inc., Guardant Health, Inc., Illumina, Inc., Isogen Life Science B.V., Menarini Group, Myriad Genetics, Inc., Neogenomics Laboratories, Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Breast Cancer Liquid Biopsy Testing Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Breast Cancer Liquid Biopsy Testing Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Breast Cancer Liquid Biopsy Testing Devices Market?
4. What is the competitive strategic window for opportunities in the Global Breast Cancer Liquid Biopsy Testing Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Breast Cancer Liquid Biopsy Testing Devices Market?
6. What is the market share of the leading vendors in the Global Breast Cancer Liquid Biopsy Testing Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Breast Cancer Liquid Biopsy Testing Devices Market?
Frequently Asked Questions about the Global Breast Cancer Liquid Biopsy Testing Devices Market

What is the estimated value of the Global Breast Cancer Liquid Biopsy Testing Devices Market?

The Global Breast Cancer Liquid Biopsy Testing Devices Market was estimated to be valued at $721.23 Million in 2022.

What is the growth rate of the Global Breast Cancer Liquid Biopsy Testing Devices Market?

The growth rate of the Global Breast Cancer Liquid Biopsy Testing Devices Market is 19.5%, with an estimated value of $3004.57 Million by 2030.

What is the forecasted size of the Global Breast Cancer Liquid Biopsy Testing Devices Market?

The Global Breast Cancer Liquid Biopsy Testing Devices Market is estimated to be worth $3004.57 Million by 2030.

Who are the key companies in the Global Breast Cancer Liquid Biopsy Testing Devices Market?

Key companies in the Global Breast Cancer Liquid Biopsy Testing Devices Market include Bio, Rad Laboratories, Inc., Biocept, Inc., Biodesix, Inc., Exact Sciences Corporation, F. Hoffmann, La Roche Ltd., Fluxion Biosciences Inc. and Illumina, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of breast cancer among women worldwide
5.1.1.2. Increasing demand for non-invasive breast cancer treatment
5.1.1.3. Surge in pre-screening programs for breast cancer detection
5.1.2. Restraints
5.1.2.1. Presence of strict standards for liquid biopsy
5.1.3. Opportunities
5.1.3.1. Technological advancements in breast cancer liquid biopsy testing devices
5.1.3.2. Investments in R&D for breast cancer testing
5.1.4. Challenges
5.1.4.1. Concerns related to the accuracy of testing devices
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Breast Cancer Liquid Biopsy Testing Devices Market, by Offerings
6.1. Introduction
6.2. Assay & Reagents Kits
6.3. Instruments

7. Breast Cancer Liquid Biopsy Testing Devices Market, by Circulating Biomarker
7.1. Introduction
7.2. Circulating Tumar DNA
7.3. Circulating Tumor Cell
7.4. Extracellular Vesicles

8. Breast Cancer Liquid Biopsy Testing Devices Market, by Applications
8.1. Introduction
8.2. Cancer Applications
8.3. Non-Cancer Applications

9. Americas Breast Cancer Liquid Biopsy Testing Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Breast Cancer Liquid Biopsy Testing Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Breast Cancer Liquid Biopsy Testing Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Bio-Rad Laboratories, Inc.
13.2. Biocept, Inc.
13.3. Biodesix, Inc.
13.4. Exact Sciences Corporation
13.5. F. Hoffmann-La Roche Ltd.
13.6. Fluxion Biosciences Inc.
13.7. Guardant Health, Inc.
13.8. Illumina, Inc.
13.9. Isogen Life Science B.V.
13.10. Menarini Group
13.11. Myriad Genetics, Inc.
13.12. Neogenomics Laboratories, Inc.
13.13. Sysmex Corporation
13.14. Thermo Fisher Scientific Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET DYNAMICS
FIGURE 11. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2022 VS 2030 (%)
FIGURE 13. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY OFFERINGS, 2030
FIGURE 15. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY ASSAY & REAGENTS KITS, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2022 VS 2030 (%)
FIGURE 18. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY CIRCULATING BIOMARKER, 2030
FIGURE 20. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMAR DNA, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMOR CELL, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY EXTRACELLULAR VESICLES, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2022 VS 2030 (%)
FIGURE 24. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATIONS, 2030
FIGURE 26. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CANCER APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY NON-CANCER APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 28. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 30. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 31. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 32. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 38. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 39. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 40. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 42. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 43. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 44. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 60. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 82. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 83. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY ASSAY & REAGENTS KITS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY ASSAY & REAGENTS KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY ASSAY & REAGENTS KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMAR DNA, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMAR DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMAR DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMOR CELL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMOR CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING TUMOR CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY EXTRACELLULAR VESICLES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CANCER APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CANCER APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CANCER APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY NON-CANCER APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY NON-CANCER APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY NON-CANCER APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 43. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 45. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 46. CANADA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 65. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 66. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 67. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 68. CHINA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 69. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 71. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 72. INDIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 77. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 79. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 80. JAPAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 101. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 103. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 104. THAILAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 114. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 116. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 117. DENMARK BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 120. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 121. EGYPT BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 124. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 125. FINLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 126. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 133. GERMANY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 138. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 139. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 140. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 141. ITALY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 150. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 152. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 153. NORWAY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 154. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 155. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 156. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 157. POLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 158. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 159. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 160. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 161. QATAR BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 174. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 176. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 177. SPAIN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 186. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 188. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 189. TURKEY BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY OFFERINGS, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY CIRCULATING BIOMARKER, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 198. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 199. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 200. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 201. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 202. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 203. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 204. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET MERGER & ACQUISITION
TABLE 205. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 206. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 207. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET INVESTMENT & FUNDING
TABLE 208. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 209. GLOBAL BREAST CANCER LIQUID BIOPSY TESTING DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • Bio-Rad Laboratories, Inc.
  • Biocept, Inc.
  • Biodesix, Inc.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fluxion Biosciences Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Isogen Life Science B.V.
  • Menarini Group
  • Myriad Genetics, Inc.
  • Neogenomics Laboratories, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...